EMT and CSC marker expression examination in 27 HCC patients by immunohistochemistry revealed downregulation of epithelial marker E-cadherin in 63 % of patients and upregulation of mesenchymal marker N-cadherin in 81 % of patients. The gene discussed is CDH1; the disease is hepatocellular carcinoma.